Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-013392

Director bought 3,000 shares at $6.23 ($18,692)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ling Geoffrey M.D. Director 2020-02-25 Purchase +3,000 $6.23 $18,692 3,000 D
Open-market purchases · 3,000 sh · avg $6.23 · $18,692
Loading xslF345X03/doc4.xml…